![]() |
市場調查報告書
商品編碼
1775448
全球呼吸照護設備市場:2025-2030 年預測Global Respiratory Care Devices Market - Forecasts from 2025 to 2030 |
呼吸護理設備市場預計將從 2025 年的 253.75 億美元成長到 2030 年的 356.5 億美元,複合年成長率為 7.04%。
老年人口不斷增加
全球人口老化是市場擴張的主要催化劑。老年人更容易患慢性阻塞性肺病(COPD) 等慢性呼吸系統疾病,這顯著增加了對呼吸照護設備的需求。日本和義大利等老年人口比例居世界首位的地區,對與老齡化相關的疾病的醫療保健需求正在增加。這些人口結構變化給醫療保健系統帶來了採用先進呼吸護理技術的壓力,從而推動了預測期內(2023-2028 年)的市場成長。老年人群中非傳染性疾病盛行率的上升,進一步推動了對有效管理慢性呼吸系統疾病的創新設備的需求。
慢性阻塞性肺病盛行率不斷上升
慢性阻塞性肺病 (COPD) 仍然是市場需求的主要驅動力,該疾病目前無法治療方法,但可以透過先進的呼吸人工呼吸器和其他呼吸支持設備的需求。由於 COPD 在老年人中更為普遍,全球人口老化將加劇這一趨勢,從而進一步推動市場成長。
早產兒數量激增
早產兒增加也是推動新生兒呼吸照護設備需求的關鍵因素。早產兒,尤其是32週前出生的早產兒,常因肺表面活性物質分泌不足而出現呼吸系統疾病,引發早產兒呼吸暫停、支氣管肺發育不良和肺炎等疾病。根據世界衛生組織統計,全球每年約有1500萬例早產,其中60%以上發生在非洲和南亞地區。中低收入國家的早產率(12%)高於高所得國家(9%)。降低呼吸系統併發症導致的新生兒死亡率的需求推動了對先進呼吸護理設備的需求,創造了巨大的市場機會。
市場區隔
技術進步
智慧通氣解決方案的創新正在改變呼吸護理設備市場。先進的系統可以根據醫生指定的目標和患者的生理輸入自動調節通氣和供氧量。這些技術正在提高易用性,改善患者預後,並推動收益的顯著成長。此類先進設備的開發代表著巨大的市場擴張機會,尤其對於患有急性或慢性呼吸系統疾病的患者。
區域洞察
由於慢性阻塞性肺病 (COPD) 等慢性呼吸系統疾病的發生率高且醫療支出高昂,北美佔據了主導市場佔有率。另一方面,由於需要呼吸支持的慢性疾病負擔沉重且老年人口眾多(尤其是在日本),亞太地區是成長最快的市場。這種區域動態凸顯了全球市場的各種成長機會。
市場挑戰
嚴格的法規環境
由於醫療設備認證的嚴格監管要求,市場面臨挑戰。 FDA 歸類為 II 類的呼吸照護器材需要透過上市前通知 (510(k))核准。雖然這些法規確保了安全性,但它們可能會延遲產品上市或增加開發成本,從而阻礙市場成長。在構思、製造、包裝和廣告方面,嚴格的查核點旨在防止誤導性宣傳,但也可能導致產品合格,進而影響市場動態。
它有什麼用途?
產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響
The Global Respiratory Care Devices Market is expected to grow from USD 25.375 billion in 2025 to USD 35.650 billion in 2030, at a CAGR of 7.04%.
Rising Geriatric Population
The global aging population is a major catalyst for market expansion. The elderly are more susceptible to chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), which significantly boosts demand for respiratory care devices. Japan, with the world's highest proportion of elderly individuals, and other regions like Italy, are seeing increased healthcare needs for age-related conditions. This demographic shift places pressure on health systems to adopt advanced respiratory care technologies, propelling market growth over the forecast period (2023-2028). The rising prevalence of non-communicable diseases among older populations further amplifies the need for innovative devices to manage chronic respiratory conditions effectively.
Increasing Prevalence of COPD
COPD remains a critical driver of market demand, with no cure but treatable through advanced respiratory care devices. Smoking, both active and passive, is a leading cause of COPD, alongside other risk factors like indoor and outdoor pollution and occupational exposures to dust and chemicals. The disease's high prevalence, particularly in low- and middle-income countries, fuels the need for ventilators and other respiratory support devices. The aging global population exacerbates this trend, as COPD is more common among older individuals, further accelerating market growth.
Surge in Preterm Births
The rising incidence of preterm births is another significant factor driving demand for neonatal respiratory care devices. Premature infants, particularly those born before 32 weeks, often suffer from respiratory disorders due to insufficient surfactant production, leading to conditions like apnea of prematurity, bronchopulmonary dysplasia, and pneumonia. According to WHO, approximately 15 million preterm births occur annually, with over 60% in African and South Asian regions. Low- and middle-income countries report higher preterm birth rates (12%) compared to high-income countries (9%). The need to reduce neonatal mortality from respiratory complications has spurred demand for advanced respiratory care devices, creating substantial market opportunities.
Market Segment Analysis
Technological Advancements
Innovations in intelligent ventilation solutions are transforming the respiratory care devices market. Advanced systems can automatically adjust ventilation and oxygenation based on physician-specified goals and patient physiological inputs. These technologies enhance ease of use and improve patient outcomes, driving significant revenue growth. The development of such sophisticated devices presents a robust opportunity for market expansion, particularly for patients with acute or chronic respiratory conditions.
Regional Insights
North America holds a dominant market share due to the high prevalence of chronic respiratory diseases like COPD and substantial healthcare expenditure. Meanwhile, the Asia-Pacific region is the fastest-growing market, driven by a high burden of chronic diseases requiring respiratory support and a significant elderly population, particularly in Japan. These regional dynamics highlight varied growth opportunities across global markets.
Market Challenges
Stringent Regulatory Environment
The market faces challenges due to rigorous regulatory requirements for medical device approvals. Respiratory care devices, classified as Class II devices by the FDA, require premarket notification (510(k)) clearance. These regulations ensure safety but can delay product launches and increase development costs, posing a barrier to market growth. Stringent checkpoints during conception, manufacturing, packaging, and advertising aim to prevent misleading claims but may lead to product disqualifications, impacting market dynamics.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation: